These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31012560)

  • 1. Observational Study of Clindamycin Phosphate and Tretinoin Gel for the Treatment of Acne.
    Ohlson J; Dakovic R; Berg M
    J Drugs Dermatol; 2019 Apr; 18(4):328-334. PubMed ID: 31012560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years.
    Eichenfield LF; Wortzman M
    Pediatr Dermatol; 2009; 26(3):257-61. PubMed ID: 19706084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
    Ochsendorf F
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():8-13. PubMed ID: 26059820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies.
    Dréno B; Bettoli V; Ochsendorf F; Layton AM; Perez M; Dakovic R; Gollnick H
    Eur J Dermatol; 2014; 24(2):201-9. PubMed ID: 24704684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
    Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
    Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study.
    Kircik LH; Peredo MI; Bucko AD; Loss RW; Fowler JF; Wortzman M; Neumaier GJ
    Cutis; 2008 Nov; 82(5):358-66. PubMed ID: 19090341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
    Lain E; Day D; Harper J; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
    Leyden J; Wortzman M; Baldwin EK
    J Drugs Dermatol; 2009 Apr; 8(4):383-8. PubMed ID: 19363857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring.
    Leyden JJ; Wortzman M
    Cutis; 2008 Aug; 82(2):151-6. PubMed ID: 18792548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
    Stein Gold L; Pariser DM; Guenin E
    J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
    Weiss JW; Shavin J; Davis M
    Clin Ther; 2002 Oct; 24(10):1706-17. PubMed ID: 12462298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
    Harper JC; Baldwin H; Stein Gold L; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
    Han G; Armstrong AW; Desai SR; Guenin E
    J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
    Amar L; Kircik LH
    J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
    Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R
    J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.